SpeedWeed

FEBRUARY 21, 2021

February 18, 2021. | Previously, Kaminski and GB Sciences had collaborated on finding mixtures of cannabinoids that would reduce inflammation caused by viruses like HIV. “If The post Cannabis mixtures studied as treatment for COVID inflammation appeared first on SpeedWeed. Published. James Hale.

Treatment 52

Treatment Research and Development Cannabinoids Data 52

TheAnswerPage

DECEMBER 3, 2021

Again, the location of the CB1 receptors helps explain some of the effects of cannabinoids that bind to CB1 receptors or influence the actions of CB1 receptors. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics (2021). Cavaletti, G., Marmiroli, P., See the Answer.

Cannabinoids 59

Cannabinoids Treatment 59

TheAnswerPage

DECEMBER 4, 2021

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics (2021). The expression of CB2 Receptors may be upregulated in the CNS and in the dorsal root ganglia during pathological pain states. Cavaletti, G., Marmiroli, P., See the Answer.

Treatment 59

Treatment Cannabinoids Conditions 59

TheAnswerPage

JULY 22, 2021

Some cannabinoid-based drugs have been approved by national drug administrations. For example, Epidiolex (a CBD product) has been approved by the US FDA for the treatment of rare pediatric seizure disorders (Lennox-Gastaut syndrome, Dravet syndrome and tuberous sclerosis complex). e58010716930, 2021. GONZAGA, R. DOI: 10.3344.

Research and Development 52

Research and Development Epilepsy Treatment Cannabinoids 52

TheAnswerPage

NOVEMBER 18, 2021

Do some cancer patients who use cannabis-based products believe that cannabinoids can cure cancer? Some patients believe that cannabinoids can cure cancer. IMPORTANT: To date, it has not been shown that cannabinoids cure cancer in humans.) Cancer Oct 2021. M Weiss et al. See the Answer.

Cannabinoids 52

Cannabinoids Patients Treatment Cannabis 52

TheAnswerPage

DECEMBER 5, 2021

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics (2021). AEA, a fatty acid neurotransmitter, acts on CB1 Receptors in the CNS, and CB2 Receptors in the periphery. Cavaletti, G., Marmiroli, P., See the Answer.

Concentrates 59

Concentrates Treatment Cannabinoids 59

TheAnswerPage

JULY 14, 2021

Also, some cannabinoids increase appetite. A thorough 2021 review article summarized the current research evaluating the relationship between cannabinoid-based medicines and the treatment of IBD. Adv Ther (2021). ” Buckley, M.C., Kumar, A. & & Swaminath, A. link] [link]. See the Answer.

Patients 59

Patients Cannabinoids Treatment Conditions 59

TheAnswerPage

DECEMBER 2, 2021

The location of the CB1 receptors helps explain some of the effects of cannabinoids that bind to CB1 receptors or influence the actions of CB1 receptors. Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics (2021). Cavaletti, G., Marmiroli, P., See the Answer.

Cannabinoids 52

Cannabinoids Treatment 52

TheAnswerPage

DECEMBER 1, 2021

Cannabinoids: an Effective Treatment for Chemotherapy-Induced Peripheral Neurotoxicity? Neurotherapeutics (2021). ” Cavaletti, G., Marmiroli, P., See the Answer.

Treatment 52

Treatment Cannabinoids 52

Cannabis Law Report

OCTOBER 5, 2021

Systematic literature review of the therapeutic value, benefits and risks of MDMA and psilocybin for the treatment of mental health conditions. 30 September 2021. On 5 August 2021, the TGA announced that an Independent Expert Panel had been established to undertake the review. Summary of the Panel Report. Terms of Reference.

Treatment 52

Treatment Conditions Medicine Clinical Trials 52

WeedAdvisor

MARCH 19, 2019

The study, which began in 2016 and is set to conclude in 2021, began by assessing the therapeutic effects of CBD in animals with brain injuries. Researchers found that complementary CBD therapy in conjunction with conventional treatment yielded better results. Currently No Medication for Concussions. . Holtz, who holds a Ph.D

Treatment 53

Treatment CBD Research and Development Therapy 53

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52

Safety Cannabinoids Events Data 52

The Cannigma

OCTOBER 2, 2022

Additionally, nausea is a common side effect of cancer treatments, migraines, pregnancy, and more. But what about CBD , which is usually considered the “more medical” cannabinoid? A 2021 study identified the antiemetic properties of CBD but adding CBD to the mix doesn’t seem to provide a clear improvement. CBDA and nausea.

Terpenes 113

Terpenes Strains THC Oil 113

TheAnswerPage

OCTOBER 25, 2021

How should the cannabinoid-based therapy be withdrawn? According to the Health Canada document entitled “Information for Health Care Professionals – Cannabis (marihuana, marijuana) and the Cannabinoids,” “If intolerable adverse effects appear without significant benefit, dosing should be tapered and stopped. Grotenhermen F.

Therapy 59

Therapy Cannabinoids Treatment Marijuana 59

Cannabis Law Report

OCTOBER 15, 2021

At Kidney Week 2021, Goldfinch Bio will present multiple e-posters, including: The design of TRACTION-2, the ongoing Phase 2 clinical trial evaluating GFB-887 for the treatment of focal segmental glomerulosclerosis (FSGS) and diabetic nephropathy (DN). Presentations at ASN Kidney Week 2021, November 4-7, 2021.

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

TheAnswerPage

MAY 18, 2021

Cannabinoids have been shown to ameliorate some of the symptoms associated with cancer and the side effects associated with some cancer treatments, however, cannabinoids have not been shown to be an effective anti-cancer agent in humans. A survey of breast cancer patients’ use of cannabis before, during, and after treatment.

Treatment 59

Treatment Cannabinoids Conditions Patients 59

TheAnswerPage

OCTOBER 18, 2021

As stated by the authors of “Brief Commentary: Cannabinoid Dosing for Chronic Pain Management” in the Annals of Internal Medicine, “We advocate a “start-low, go-slow” dosing philosophy, applied to both quantity and adverse effect profiles. “We Brief Commentary: Cannabinoid Dosing for Chronic Pain Management Ann Intern Med.

Chronic Pain 52

Chronic Pain Therapy Cannabinoids Extraction 52

TheAnswerPage

APRIL 29, 2021

Do some cannabinoids reduce spasticity? The cannabinoids act on the presynaptic CB1 receptors, and the receptor activation reduces massive glutamate release and regulates glutamatergic excitability during spasticity.

Cannabinoids 59

Cannabinoids Extraction Treatment Medicine 59

TheAnswerPage

OCTOBER 21, 2021

How long should the testing period of a cannabinoid-based drug be? According to the European Pain Federation position paper on the appropriate use of cannabis-based medicines, “a testing period of maximum 3 months should be considered both by patients and prescribers [or recommenders], to assess treatment efficacy and safety.

Chronic Pain 59

Chronic Pain Treatment Therapy Safety 59

TheAnswerPage

AUGUST 19, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

JULY 5, 2021

There is a high strength of evidence for the efficacy of cannabinoid-based medicines for the treatment of intractable epilepsy, multiple sclerosis and cancer-related nausea. Which of these 3 conditions has the greatest relative number of patients using cannabinoid -based medicines to treat the condition? Schlag, A.K.,

Epilepsy 52

Epilepsy Cannabinoids Medicine Conditions 52

Veriheal

DECEMBER 8, 2021

Fortunately, a new study found that cannabidiol (CBD) can be useful in the treatment of traumatic brain injury. Adding to the seriousness of a TBI is the fact that there are currently no universally effective treatments—which is what makes the findings of this new study especially significant. or CBDi treatment alone.”

CBD 98

CBD Treatment Therapy Chronic Pain 98

TheAnswerPage

JUNE 14, 2021

The oromucosal spray Sativex (nabiximols) is a cannabis extract that contains the principal cannabinoids delta-9-tetrahydrocannibinol (THC) and cannabidiol (CBD) in a 50:50 ratio, as well as specific minor cannabinoids and other non-cannabinoid components. ” GW Pharmaceuticals website.

Nerve Pain 52

Nerve Pain Epilepsy Pharmaceutical Cannabinoids 52

TheAnswerPage

JULY 7, 2021

According to the Minnesota database and other reports, the number of people using cannabinoid-based medicines to treat PTSD is increasing. Does the literature support the use of cannabinoids to treat PTSD?

Cannabinoids 52

Cannabinoids Sleep Treatment Patients 52

Veriheal

AUGUST 16, 2023

In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.

CBD 98

CBD Research and Development Treatment Policy 98

TheAnswerPage

JANUARY 11, 2022

As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronic pain but were unable to answer their patients’ questions” (1).

Patients 98

Patients Education Marijuana Therapy 98

TheAnswerPage

MAY 17, 2021

Epidemiological studies indicate that as many as 15% of inflammatory bowel disease (IBD) patients may use cannabinoids to ameliorate some of their symptoms, including improvement in diarrhea, abdominal pain and appetite. Do the studies show that cannabinoids are effective in Crohn’s disease? Naftali T, Dor M. doi:10.5041/RMMJ.10390.

Cannabinoids 52

Cannabinoids Treatment Medicine THC 52

TheAnswerPage

MAY 13, 2021

Are cannabinoids an effective analgesic agent in the acute pain setting? Are cannabinoids an effective analgesic agent in the chronic pain setting? In contrast to the lack of efficacy in the acute pain setting, cannabinoids are effective analgesic agents in the chronic pain setting. Vulfsons S, Minerbi A, Sahar T. See Answer.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment THC 52

TheAnswerPage

MAY 14, 2021

According to the results of a survey of breast cancer patients’ use of cannabinoid products, 42% of survey participants had used medical cannabinoid products to relieve symptoms. What symptoms were treated with cannabinoid products? A survey of breast cancer patients’ use of cannabis before, during, and after treatment.

Cannabinoids 52

Cannabinoids Patients Treatment Cannabis 52

MMJ Recs

MAY 30, 2021

And how much does it cost to get an MMJ card in California in 2021? How Do You Get A Medical Card In California In 2021? How Much Does It Cost To Get A Medical Card In California In 2021? A California medical marijuana card costs $50 in 2021. Do You Still Need A Medical Card In California In 2021?

Dispensary 52

Dispensary Recreational Tincture Chronic Pain 52

TheAnswerPage

MAY 29, 2021

A common adverse effect of chronic recreational marijuana use is cannabinoid hyperemesis syndrome. In fact, cannabinoid hyperemesis syndrome is a near daily diagnosis in many Canadian emergency departments. Anecdotal evidence supports the use of haloperidol to treat cannabinoid hyperemesis syndrome. mg/kg or 0.1

Clinical Trials 52

Clinical Trials Cannabinoids Treatment Recreational 52

TheAnswerPage

AUGUST 9, 2021

The FDA has approved a CBD product (Epidiolex) for the treatment of 3 rare forms of epilepsy. Cannabidiol does not appear to exert its anticonvulsant effects through interaction with cannabinoid receptors.” What is the mechanism of action of CBD in this anti-epileptic medication? How does CBD exert its anti-convulsant effects?

Epilepsy 52

Epilepsy Treatment Cannabinoids CBD 52

TheAnswerPage

JULY 22, 2022

The “Cannabinoid-based Medications for the Treatment of Chronic Pain” series continues… As described in the previous Answer of the Day, the September 9, 2021 edition of the British Medical Journal contained the guidelines entitled “Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline.”

Chronic Pain 52

Chronic Pain Sleep Cannabinoids Therapy 52

TheAnswerPage

JUNE 4, 2021

The FDA has approved a CBD product (Epidiolex) for the treatment of 3 rare forms of epilepsy. Cannabidiol does not appear to exert its anticonvulsant effects through interaction with cannabinoid receptors.” What is the mechanism of action of CBD in this anti-epileptic medication? How does CBD exert its anti-convulsant effects?

Epilepsy 52

Epilepsy Treatment Cannabinoids CBD 52

TheAnswerPage

JULY 23, 2022

The “Cannabinoid-based Medications for the Treatment of Chronic Pain” series continues… The “Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline” was published in the September 9, 2021 edition of the British Medical Journal. See the Answer.

Chronic Pain 52

Chronic Pain Cannabinoids Treatment Cannabis 52

TheAnswerPage

NOVEMBER 11, 2021

Nabilone is a synthetic cannabinoid that is similar in structure to delta-9-THC and is for oral administration. Nabilone is used for the treatment of chemotherapy-induced nausea and vomiting. What is the recommended dosage of nabilone? As per the package insert, the usual dose of nabilone is 1 or 2 mg twice daily.

Therapy 52

Therapy Pharmaceutical Packaging Treatment 52

TheAnswerPage

NOVEMBER 12, 2021

Nabiximols is indicated as treatment for symptom improvement in adult patients with moderate to severe spasticity due to multiple sclerosis who have not responded adequately to other anti-spasticity medication and who demonstrate clinically significant improvement in spasticity related symptoms during an initial trial of therapy.

Therapy 59

Therapy Patients Treatment Cannabinoids 59